115 related articles for article (PubMed ID: 1613989)
1. [11-Dehydro-TXB2 and 2,3-dinor-TXB2 as new parameters of TXA2 generation].
Katori M; Kawamura M; Sawada M
Nihon Rinsho; 1992 Feb; 50(2):349-54. PubMed ID: 1613989
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals.
Kawamura M; Harada Y; Katori M
Thromb Res; 1995 Mar; 77(5):465-74. PubMed ID: 7778061
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
5. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
[TBL] [Abstract][Full Text] [Related]
6. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2 biosynthesis in human disease.
FitzGerald GA; Healy C; Daugherty J
Fed Proc; 1987 Jan; 46(1):154-8. PubMed ID: 3100340
[TBL] [Abstract][Full Text] [Related]
8. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs.
Yamanaka S; Miura K; Yukimura T; Yamamoto K
Prostaglandins; 1993 Mar; 45(3):221-8. PubMed ID: 8484010
[TBL] [Abstract][Full Text] [Related]
9. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Catella F; Healy D; Lawson JA; FitzGerald GA
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5861-5. PubMed ID: 3461463
[TBL] [Abstract][Full Text] [Related]
10. [Urinary 11-dehydro thromboxane B2 during toxemic pregnancies].
Kobayashi S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):715-21. PubMed ID: 1890349
[TBL] [Abstract][Full Text] [Related]
11. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites.
Forastiero R; Martinuzzo M; Carreras LO; Maclouf J
Thromb Haemost; 1998 Jan; 79(1):42-5. PubMed ID: 9459320
[TBL] [Abstract][Full Text] [Related]
14. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
15. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo.
Bode-Böger SM; Böger RH; Kienke S; Böhme M; Phivthong-ngam L; Tsikas D; Frölich JC
Cardiovasc Res; 1998 Mar; 37(3):756-64. PubMed ID: 9659460
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
17. Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2.
Katayama S; Inaba M; Maruno Y; Omoto A; Kawazu S; Ishii J; Sawada M
Prostaglandins Leukot Essent Fatty Acids; 1990 Jan; 39(1):47-51. PubMed ID: 2339136
[TBL] [Abstract][Full Text] [Related]
18. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man.
Ciabattoni G; Pugliese F; Davi G; Pierucci A; Simonetti BM; Patrono C
Biochim Biophys Acta; 1989 Jul; 992(1):66-70. PubMed ID: 2752040
[TBL] [Abstract][Full Text] [Related]
19. Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production.
Westlund P; Kumlin M; Nordenström A; Granström E
Prostaglandins; 1986 Mar; 31(3):413-43. PubMed ID: 3520685
[TBL] [Abstract][Full Text] [Related]
20. [Changes in platelet sensitivity to thromboxane A2 in pediatric patients with nephrotic syndrome].
Watanabe M; Suzuki J; Suzuki H
Nihon Jinzo Gakkai Shi; 1996 Aug; 38(8):356-63. PubMed ID: 8828355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]